Vision R&D

🌟 An outstanding achievement in our pursuit of eye health!

We are excited to highlight one of our most recent projects that focused on herpes virus detection in corneal transplant donor tissue: "Complement to the project to detect herpes virus I, II, III, IV and V contamination in corneal transplant donor tissue as a cause of postoperative infection". It was made possible by funding from the Regional Health Management of the Junta de Castilla y León in 2021.

We remain committed to innovation for a healthier future. 🔬🌐

Eyes on Excellence

Discover CELAB👁️🔬

It offers you:

🔬 Clinical Trials Unit.
🔍 Ocular Surface Research Group.
🧪 Ocular Immunology & Oculofacial Pain Unit (UNIDOF).
📊 Statistical Unit.
🏆 Quality Control Unit.

We strive for a future with a clearer vision! 👓💡

First meeting of the working team on Evaluation, Safety & Research in Medical Devices for ophthalmologic use. Multidisciplinary team formed by ophthalmologists, chemists, engineers and technicians.

🥇 We strive to provide the best solution to our customers.

🏥 Why use CELab?🔬

Vision R&D on LinkedIn: #clinicalresearch #celab #spiketechnology #visionrd 🏥 Why use CELab?🔬 🔍 In the context of clinical trials, CELab plays a crucial role in achieving the desired success. 💼 This importance becomes even more…

🤝 Ayer concluyó la participación de Sodical, empresa de capital-riesgo de la Junta de Castilla y León, que nos ha apoyado y ayudado a través de un préstamo participativo durante unos años muy duros. Hoy queremos transmitirles nuestro más sincero agradecimiento, por su ayuda inestimable y su flexibilidad. Para nosotros ha sido una satisfacción poder devolver el préstamo y las participaciones. Gracias por seguir ayudando a las pequeñas empresas de Castilla y León. 🤝

🤝 Yesterday, the participation of Sodical, a venture capital company of the Junta de Castilla y León, which has supported and helped us through a participative loan during some very difficult years, came to an end. Today we would like to thank them most sincerely for their invaluable help and flexibility. It has been a great satisfaction for us to be able to repay the loan and the shares. Thank you for continuing to help the small companies of Castilla y León. 🤝

MDR 2017/745 implementation raise challenges for medical devices companies in Europe.
🤝 we join forces with and to assist companies to comply with the MDR and stand out in the market 🚀

🌍 Clinical and research experts in ocular medical devices.
📋Assistance in classification, quality management or CE evaluation.
🔬Validation, preclinical and clinical development, safety and scientific reports.

💡 🔬 We are very proud that Margarita Calonge, one of our scientific advisors, is among the top 1000 Spanish women researchers. Thank you for your hard work and dedication🏅

https://www.elnortedecastilla.es/valladolid/siete-investigadoras-valladolid-mejores-cientificas-espanolas-segun-20230605205031-nt.html

🤝🔍 In our company, we strive to provide exceptional service based on strong principles and values. We are guided by professional ethics, innovation, social responsibility, and a commitment to customer satisfaction.

🌎🚀 We take pride in exporting our services to clients around the world. From North America to Europe and Asia, our clients trust in our expertise and commitment to quality.

❗ Buscamos candidatos para solicitar una tesis doctoral bajo el programa Doctorado Industrial del Ministerio de Ciencia el Innovación. 👉 https://www.aei.gob.es/convocatorias/buscador-convocatorias/ayudas-contratos-formacion-doctores-empresas-doctorados-24

Tema: Identificación de los factores de riesgo en la calcificación de las lentes intraoculares y propuestas de mejora para fabricación de nuevos modelos

Perfil: química, química orgánica, ingeniería biomédica, química analítica, ingeniería de materiales para biomedicina o áreas afines.

Recepción de solicitudes: hasta el 15 de febrero. Enviar CV adjunto a [email protected] (Asunto: Solicitud Doctorado Industrial)

Retribución (si concede): 19.000 euros brutos anuales

Para más información, contactar con [email protected]

www.aei.gob.es

On Wednesday, February 1st, the next IOBA UVa research webinar will take place. Marta Blanco Vázquez will talk about "Potential biomarkers for chronic ocular pain associated with dry eye disease". This project has been conducted in the Controlled Environment Laboratory of Vision R&D. Don't miss it!

Link to the webinar: http://bit.ly/3iZ8k5y

👁Are you aware of MDR updates?

As we continue our efforts to support the implementation of the new Medical Devices Regulation (EU) 2017/745 (MDR), we want to keep you up to date on all relevant news and events. You will find the latest updates here:

Medical Devices - Sector Medical Devices - Sector

Last week VISION R&D has participated in the divulgative sessions of the "Science Week" organized by IOBA

We are pleased to announce the incorporation of Dr. Cristina Andrés Iglesias to the staff of VISION R&D, whose contract is co-financed by the Torres Quevedo grant awarded by the Ministry of Science and Innovation and the State Research Agency (10.13039/501100011033).

She is an engineering, associate professor in the organic chemistry department of the University of Valladolid and principal researcher in safety of Medical Devices. She is expert in gas chromatography-mass spectrometry (GC-MS), in chemical analysis of toxic compounds in medical devices and in the development of new medical devices. Also, she is Technical Expert of ISO 16672: ophthalmic implants, ocular endotamponades.

Congratulations and Welcome!

👁️ Are you looking for experimental models of ocular diseases? 👁️

IOBA and VISION R&D offer experimental models of ocular diseases to the industry or scientific groups. These models are supported by scientific publications and years of experience. Importantly, the studies are carried out under quality standards (ISO 9001 and Good Laboratory Practice).

Preclinical Platform – Vision R&D State of the art solutions

The Ocular Surface Group of the IOBA UVa has recently published a prospective study conducted at the Controlled Environment Laboratory (CELab). The prophylactic effect of LipiFlow treatment was assessed in Meibomian gland dysfunction patients exposed to an adverse controlled environment. The results reveal that a single session of LipiFlow treatment can improve objective and subjective outcomes of the lacrimal functional unit in Meibomian gland dysfunction patients assessed under controlled environmental conditions. Moreover, the benefits of the therapy are sustained for at least one-year post-treatment.

Adverse environmental conditions (such as low humidity, air flows, temperature variations…) are very common in our daily life. This study supports the usefulness of the CELab to recreate these adverse environments to test the efficacy of a therapy.

Open access: https://lnkd.in/ei7x_NP5

Congratulations to all the authors!

👁 Do you know CELab?

The Controlled Environment Laboratory (CELab) is a unique facility composed of an exposure chamber, an evaluation chamber, and all the experience of the Institute of Applied Ophthalmobiology (IOBA) of the University of Valladolid. CELab offers cutting edge technology to carry out high quality research and customized clinical trials.

The CELab benefits are:
1. More reliable diagnostic test values that reduce the number of subjects necessary to obtain statistically significant results.
2. By running a large amount of evaluation tests and biomarkers, the efficacy of the potential therapeutic candidate is widely defined.
3. The most valid end-points can be selected for further multicenter clinical trials, eliminated those that showed no signal.
4. Ability to obtain a “yes/no” answer before running a large sample of patients for multicenter clinical trials with registration purposes.
5. Increases speed and saves economical resources in drug development, registration, and commercialization programs.

👁 Do you know VISION R&D?

We are focused into those four lines of business. We want to emphasize that we are delighted to help researchers from any University, Hospital or group, from anywhere in the world, to develop their projects. We put all our experience at their service. And the possibilities of collaborating are multiple.
Please contact us: [email protected]

Vision R&D updated their business hours.

It's now easier to email Vision R&D